T-5224
Based on 102 publication(s) in Google Scholar
T-5224 is a transcription factor c-Fos/activator protein (AP)-1 inhibitor with anti-inflammatory effects, which specifically inhibits the DNA binding activity of c-Fos/c-Jun without affecting other transcription factors. T-5224 inhibits the IL-1β-induced up-regulation of Mmp-3, Mmp-13 and Adamts-5 transcription.
For research use only. We do not sell to patients.
- Purity: 99.35%
- CAS No.: 530141-72-1
- Formula: C29H27NO8
- Molecular Weight:517.53
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) T-5224
More- Signal Transduct Target Ther. 2025 Oct 28;10(1):357. [Abstract]
- Signal Transduct Target Ther. 2024 Mar 25;9(1):74. [Abstract]
- Signal Transduct Target Ther. 2022 Jul 11;7(1):222. [Abstract]
- Nature. 2026 Apr;652(8110):774-783. [Abstract]
- Mol Cancer. 2025 Dec 16;25(1):1. [Abstract]
- Cell Stem Cell. 2017 May 4;20(5):621-634.e6. [Abstract]
- Cell Stem Cell. 2016 Sep 1;19(3):326-40. [Abstract]
- Nat Cell Biol. 2025 Dec;27(12):2143-2151. [Abstract]
- Cell Host Microbe. 2025 Aug 19:S1931-3128(25)00291-4. [Abstract]
- Cancer Res. 2024 Sep 16;84(18):2985-3003. [Abstract]
- Sci Immunol. 2021 Jan 29;6(55):eabd3489. [Abstract]
- Nat Commun. 2025 Dec 2;16(1):10831. [Abstract]
- Nat Commun. 2025 Mar 15;16(1):2565. [Abstract]
- Nat Commun. 2024 Nov 30;15(1):10422. [Abstract]
- Nat Commun. 2024 Dec 3;15(1):10536. [Abstract]
- Nat Commun. 2024 Feb 3;15(1):1038. [Abstract]
- Nat Commun. 2022 Nov 4;13(1):6648. [Abstract]
- Nat Commun. 2022 Jun 21;13(1):3545. [Abstract]
- Nat Commun. 2018 Oct 8;9(1):4122. [Abstract]
- Nat Commun. 2018 Jul 13;9(1):2727. [Abstract]
- Theranostics. 2025 Jan 1;15(4):1320-1337. [Abstract]
- Theranostics. 2020 Aug 29;10(23):10712-10728. [Abstract]
- J Nanobiotechnology. 2026 Mar 6;24(1):345. [Abstract]
- Sci Adv. 2023 Apr 14;9(15):eadf8522. [Abstract]
- Carbohydr Polym. 2019 Mar 1;207:502-509. [Abstract]
- Cell Rep Med. 2025 Jan 16:101922. [Abstract]
- Cancer Lett. 2021 May 28:506:23-34. [Abstract]
- Adv Healthc Mater. 2024 Mar;13(7):e2302901. [Abstract]
- Cell Death Dis. 2023 Jul 21;14(7):455. [Abstract]
- Cell Death Dis. 2020 Jul 6;11(7):501. [Abstract]
- Proc Natl Acad Sci U S A. 2026 May 5;123(18):e2601788123. [Abstract]
- Osteoarthritis Cartilage. 2024 Feb;32(2):187-199. [Abstract]
- Cell Commun Signal. 2024 Oct 3;22(1):473. [Abstract]
- Dev Cell. 2025 Mar 24;60(6):819-836.e7. [Abstract]
- Int J Biol Macromol. 2024 Jul 18:134024. [Abstract]
- Int J Biol Macromol. 2021 Aug 31:185:907-916. [Abstract]
- EMBO J. 2024 Oct;43(20):4578-4603. [Abstract]
- EMBO J. 2024 Nov;43(21):4846-4869. [Abstract]
- EMBO J. 2022 Mar 1;41(5):e109386. [Abstract]
- J Transl Med. 2025 Jan 2;23(1):1. [Abstract]
- Biomed Pharmacother. 2022 Aug;152:113258. [Abstract]
- Oncogene. 2023 Jan;42(2):138-153. [Abstract]
- Neurotherapeutics. 2026 Feb 12:e00853. [Abstract]
- Cell Rep. 2025 Aug 12;44(8):116144. [Abstract]
- Cell Rep. 2024 Dec 13;43(12):115057. [Abstract]
- Clin Transl Med. 2022 May;12(5):e798. [Abstract]
- Clin Transl Med. 2021 Aug;11(8):e500. [Abstract]
- Elife. 2023 Dec 6:12:RP88874. [Abstract]
- Cell Mol Life Sci. 2025 Jan 21;82(1):45. [Abstract]
- EMBO Rep. 2023 Dec 6;24(12):e57176. [Abstract]
- Cell Biosci. 2022 May 26;12(1):70. [Abstract]
- Ecotoxicol Environ Saf. 2025 Sep 15:303:119046. [Abstract]
- JCI Insight. 2025 Apr 22;10(8):e186812. [Abstract]
- Cell Prolif. 2024 Jul 2:e13702. [Abstract]
- Biochem Pharmacol. 2018 Sep:155:275-287. [Abstract]
- Chem Biol Interact. 2024 Dec 1:404:111262. [Abstract]
- Cancer Metab. 2024 Jul 8;12(1):20. [Abstract]
- Commun Biol. 2023 Jan 16;6(1):52. [Abstract]
- Life Sci. 2020 Nov 15;261:118360. [Abstract]
- Stem Cells Transl Med. 2025 Apr 22;14(4):szaf009. [Abstract]
- Int J Mol Sci. 2022 Oct 18;23(20):12454. [Abstract]
- FASEB J. 2023 Sep;37(9):e23112. [Abstract]
- J Inflamm Res. 2025 Apr 28:18:5727-5739. [Abstract]
- Sci Rep. 2025 Nov 17;15(1):40227. [Abstract]
- Aquaculture. 2025 Apr 15.
- Sci Rep. 2020 Oct 22;10(1):18119. [Abstract]
- Clin Transl Immunology. 2024 Apr 15;13(4):e1503. [Abstract]
- J Virol. 2023 Jun 29;97(6):e0028423. [Abstract]
- Am J Pathol. 2024 Aug 31:S0002-9440(24)00328-6. [Abstract]
- Stem Cells Int. 2019 Dec 31;2019:6461580. [Abstract]
- Endocrinology. 2017 Nov 1;158(11):4064-4075. [Abstract]
- Pathol Res Pract. 2023 Oct:250:154827. [Abstract]
- Int Immunol. 2023 Oct 6;35(10):497-509. [Abstract]
- Cell Immunol. 2026 Apr 6:425:105103. [Abstract]
- Toxicol Lett. 2023 Jan 15:373:184-193. [Abstract]
- Mol Pain. 2025 Jan-Dec:21:17448069251323668. [Abstract]
- BMC Pulm Med. 2022 Jan 6;22(1):9. [Abstract]
- Biomed Res Int. 2023 Jan 12:2023:4050730. [Abstract]
- J Orthop Res. 2017 Feb;35(2):311-320. [Abstract]
- Biochem Biophys Rep. 2025 Jul 17:43:102164. [Abstract]
- In Vitro Cell Dev Biol Anim. 2025 Aug;61(7):886-897. [Abstract]
- bioRxiv. 2026 Mar 18.
- Res Sq. 2026 Jan 9.
- Npj Viruses. 2025 Sep 18;3(1):69. [Abstract]
- bioRxiv. 2025 Aug 21:2025.08.15.670603. [Abstract]
- bioRxiv. 2025 Aug 12.
- University of the Balearic Islands. 2025 Jul 11.
- Indiana University. 2025.
- Res Sq. 2025 Apr 03.
- bioRxiv. 2025 April 14.
- Columbia University. 2025.
- bioRxiv. 2025 January 18.
- bioRxiv. 2024 November 06.
- bioRxiv. 2024 May 17.
- Universidad Del Pais Vasco. 2023 Jun 22.
- SSRN. 2023 Sep 8.
- bioRxiv. 2023 Aug 14.
- bioRxiv. 2023 Aug 20.
- Research Square Preprint. 2023 May 16.
- Int J Biol Sci. 2022 Jan 16;18(4):1363-1380. [Abstract]
- Research Square Preprint. 2020 Jun.
- ACS Comb Sci. 2019 Dec 9;21(12):805-816. [Abstract]
-
IP
-
RT-PCR
-
WB
-
WB
-
WB
All AP-1 Isoforms
More
Biological Activity
|
c-Fos |
FOSL1 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| NIH3T3 | IC50 |
10 μM
Compound: 51
|
Inhibition of AP-1 (unknown origin) expressed in TPA-stimulated mouse NIH3T3 cells by luciferase reporter gene assay
Inhibition of AP-1 (unknown origin) expressed in TPA-stimulated mouse NIH3T3 cells by luciferase reporter gene assay
|
[PMID: 24831826] |
T-5224 inhibits in-vitro production of the mediators MMP-1, MMP-3, IL-6 and TNF-α by IL-1β-stimulated human synovial SW982 cells with the mean IC50 of about 10 μM[2].
T-5224 (0-80 μM) significantly inhibits the invasion, migration, and MMP activity of HSC-3-M3 cells in a dose-dependent manner[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
G2 is observed in rat and monkey liver microsomes as a major metabolite of T-5224, suggesting that G2 is not a human-specific metabolite[5].
T-5224 (300 mg/kg, p.o.) inhibits the production of TNF-alpha and other downstream effectors in C57BL/6 mice[6].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 530141-72-1
-
Appearance Solid
-
Molecular Weight 517.53
-
Formula C29H27NO8
-
Color White to light yellow
-
SMILES
OC1=NOC2=CC(COC3=C(CCC(O)=O)C=C(C(C4=C(O)C=C(OC5CCCC5)C=C4)=O)C=C3)=CC=C21
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (102)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
Piezo1 activation suppresses bone marrow adipogenesis to prevent osteoporosis by inhibiting a mechanoinflammatory autocrine loop. [Abstract]2025 Oct 28;10(1):357. PMID: 41145414
T-5224 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2025 Oct 28;10(1):357. [Abstract]
WT and KO BMMSCs were treated with the AP-1-specific inhibitor T-5224 (10 μM) for 24 h.
-
Signal Transduct Target Ther
SARS-CoV-2 envelope protein impairs airway epithelial barrier function and exacerbates airway inflammation via increased intracellular Cl- concentration. [Abstract]2024 Mar 25;9(1):74. PMID: 38528022
T-5224 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2024 Mar 25;9(1):74. [Abstract]
Quantitative real-time PCR analyses showing the effect of C29 (50 μM), SP600125 (10 μM) and the selective AP-1 inhibitor T-5224 (10 μM) on the expression of tumor necrosis factor-α (TNF-α) in BEAS-2B cells stimulated with E protein (50 μg/mL) for 12 h.
-
Signal Transduct Target Ther
Dihydroartemisinin regulates immune cell heterogeneity by triggering a cascade reaction of CDK and MAPK phosphorylation. [Abstract]2022 Jul 11;7(1):222. PMID: 35811310
T-5224 purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2022 Jul 11;7(1):222. [Abstract]
The expression of CDK2 in the splenic cells of mice treated with DHA alone, DHA with the T-5224 inhibitor and CMC control was examined with specific antibodies. The upregulatory effect of DHA on CDK2 was significantly inhibited by T-5224 (30 mg/kg; per day by oral gavage for 8 days), a specific inhibitor of C-Fos. Molecular weight (kDa) was labeled at the right.
-
Nature
2026 Apr;652(8110):774-783. PMID: 41882356 -
Mol Cancer
2025 Dec 16;25(1):1. PMID: 41398956 -
Cell Stem Cell
Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. [Abstract]2017 May 4;20(5):621-634.e6. PMID: 28285905 -
Cell Stem Cell
An Isogenic Human ESC Platform for Functional Evaluation of Genome-wide-Association-Study-Identified Diabetes Genes and Drug Discovery. [Abstract]2016 Sep 1;19(3):326-40. PMID: 27524441 -
Nat Cell Biol
DNA fragmentation factor B suppresses interferon to enable cancer persister cell regrowth. [Abstract]2025 Dec;27(12):2143-2151. PMID: 41249572 -
Cell Host Microbe
2025 Aug 19:S1931-3128(25)00291-4. PMID: 40848719 -
Cancer Res
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment. [Abstract]2024 Sep 16;84(18):2985-3003. PMID: 38885318 -
Sci Immunol
Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases. [Abstract]2021 Jan 29;6(55):eabd3489. PMID: 33514640 -
Nat Commun
Human pluripotent stem cell-derived skin organoids enabled pathophysiological model of Mycobacterium tuberculosis infection. [Abstract]2025 Dec 2;16(1):10831. PMID: 41331115 -
Nat Commun
Single-cell and chromatin accessibility profiling reveals regulatory programs of pathogenic Th2 cells in allergic asthma. [Abstract]2025 Mar 15;16(1):2565. PMID: 40089475 -
Nat Commun
The dysadherin/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression. [Abstract]2024 Nov 30;15(1):10422. PMID: 39613801 -
Nat Commun
CRL3Keap1 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression. [Abstract]2024 Dec 3;15(1):10536. PMID: 39627198 -
Nat Commun
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. [Abstract]2024 Feb 3;15(1):1038. PMID: 38310103 -
Nat Commun
2022 Nov 4;13(1):6648. PMID: 36333322 -
Nat Commun
2022 Jun 21;13(1):3545. PMID: 35729232 -
Nat Commun
Time units for learning involving maintenance of system-wide cFos expression in neuronal assemblies. [Abstract]2018 Oct 8;9(1):4122. PMID: 30297716 -
Nat Commun
Infralimbic cortex is required for learning alternatives to prelimbic promoted associations through reciprocal connectivity. [Abstract]2018 Jul 13;9(1):2727. PMID: 30006525 -
Theranostics
JARID1D-dependent androgen receptor and JunD signaling activation of osteoclast differentiation inhibits prostate cancer bone metastasis through demethylating H3K4. [Abstract]2025 Jan 1;15(4):1320-1337. PMID: 39816691 -
Theranostics
M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation. [Abstract]2020 Aug 29;10(23):10712-10728. PMID: 32929376 -
J Nanobiotechnology
Matrix micro/nano-topography drives oncogenic signaling and drug response in a 3D osteosarcoma model. [Abstract]2026 Mar 6;24(1):345. PMID: 41787498 -
Sci Adv
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism. [Abstract]2023 Apr 14;9(15):eadf8522. PMID: 37058562 -
Carbohydr Polym
Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. [Abstract]2019 Mar 1;207:502-509. PMID: 30600033 -
Cell Rep Med
MFGE8 induces anti-PD-1 therapy resistance by promoting extracellular vesicle sorting of PD-L1. [Abstract]2025 Jan 16:101922. PMID: 39842432 -
Cancer Lett
2021 May 28:506:23-34. PMID: 33652085 -
Adv Healthc Mater
Porous Titanium Scaffolds with Mechanoelectrical Conversion and Photothermal Function: A Win-Win Strategy for Bone Reconstruction of Tumor-Resected Defects. [Abstract]2024 Mar;13(7):e2302901. PMID: 38102773 -
Cell Death Dis
ZIC2 induces pro-tumor macrophage polarization in nasopharyngeal carcinoma by activating the JUNB/MCSF axis. [Abstract]2023 Jul 21;14(7):455. PMID: 37479694 -
Cell Death Dis
TIGAR/AP-1 axis accelerates the division of Lgr5- reserve intestinal stem cells to reestablish intestinal architecture after lethal radiation. [Abstract]2020 Jul 6;11(7):501. PMID: 32632140 -
Proc Natl Acad Sci U S A
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma. [Abstract]2026 May 5;123(18):e2601788123. PMID: 42054368 -
Osteoarthritis Cartilage
Advanced glycation end products promote intervertebral disc degeneration by transactivation of matrix metallopeptidase genes. [Abstract]2024 Feb;32(2):187-199. PMID: 37717904 -
Cell Commun Signal
Punicalagin as a novel selective aryl hydrocarbon receptor (AhR) modulator upregulates AhR expression through the PDK1/p90RSK/AP-1 pathway to promote the anti-inflammatory response and bactericidal activity of macrophages. [Abstract]2024 Oct 3;22(1):473. PMID: 39363344 -
Dev Cell
Morphogenesis and regeneration share a conserved core transition cell state program that controls lung epithelial cell fate. [Abstract]2025 Mar 24;60(6):819-836.e7. PMID: 39667932 -
Int J Biol Macromol
Jun and JunB members of the AP-1 complex are potential therapeutic targets for silicosis. [Abstract]2024 Jul 18:134024. PMID: 39032899 -
Int J Biol Macromol
Molecular mechanisms underlying macrophage immunomodulatory activity of Rubus chingii Hu polysaccharides. [Abstract]2021 Aug 31:185:907-916. PMID: 34242647 -
EMBO J
A non-canonical repressor function of JUN restrains YAP activity and liver cancer growth. [Abstract]2024 Oct;43(20):4578-4603. PMID: 39210147 -
EMBO J
PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis. [Abstract]2024 Nov;43(21):4846-4869. PMID: 39160276 -
EMBO J
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs. [Abstract]2022 Mar 1;41(5):e109386. PMID: 35112724 -
J Transl Med
FOSL1 transcriptionally dictates the Warburg effect and enhances chemoresistance in triple-negative breast cancer. [Abstract]2025 Jan 2;23(1):1. PMID: 39748430 -
Biomed Pharmacother
Peucedanum praeruptorum Dunn polysaccharides regulate macrophage inflammatory response through TLR2/TLR4-mediated MAPK and NF-κB pathways. [Abstract]2022 Aug;152:113258. PMID: 35709651 -
Oncogene
Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2/ NF-κB pathway. [Abstract]2023 Jan;42(2):138-153. PMID: 36396726 -
Neurotherapeutics
KITENIN-CCL20 axis is a potential therapeutic target for modulating immunosuppressive tumor microenvironment in glioblastoma. [Abstract]2026 Feb 12:e00853. PMID: 41688273 -
Cell Rep
Early time window for memory ensemble allocation specifically depending on activity in Syt2+ early-born parvalbumin interneurons. [Abstract]2025 Aug 12;44(8):116144. PMID: 40802515 -
Cell Rep
Pancreatic β cell interleukin-22 receptor subunit alpha 1 deficiency impairs β cell function in type 2 diabetes via cytochrome b5 reductase 3. [Abstract]2024 Dec 13;43(12):115057. PMID: 39675006 -
Clin Transl Med
Single-cell profiling-guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma. [Abstract]2022 May;12(5):e798. PMID: 35522945 -
Clin Transl Med
2021 Aug;11(8):e500. PMID: 34459128 -
Elife
Sustained store-operated calcium entry utilizing activated chromatin state leads to instability in iTregs. [Abstract]2023 Dec 6:12:RP88874. PMID: 38055613 -
Cell Mol Life Sci
Sirtuin 2 exacerbates renal tubule injury and inflammation in diabetic mice via deacetylation of c-Jun/c-Fos. [Abstract]2025 Jan 21;82(1):45. PMID: 39833479 -
EMBO Rep
Role and mechanism of PVN-sympathetic-adipose circuit in depression and insulin resistance induced by chronic stress. [Abstract]2023 Dec 6;24(12):e57176. PMID: 37870400 -
Cell Biosci
2022 May 26;12(1):70. PMID: 35619122 -
Ecotoxicol Environ Saf
JunB orchestrates macrophage-fibroblast crosstalk in silica nanoparticle-induced pulmonary fibrosis. [Abstract]2025 Sep 15:303:119046. PMID: 40945089 -
JCI Insight
2025 Apr 22;10(8):e186812. PMID: 40260916 -
Cell Prolif
Abnormal HCK/glutamine/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis. [Abstract]2024 Jul 2:e13702. PMID: 38956970 -
Biochem Pharmacol
A novel fluorinated triazole derivative suppresses macrophage activation and alleviates experimental colitis via a Twist1-dependent pathway. [Abstract]2018 Sep:155:275-287. PMID: 30028990
T-5224 purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2018 Sep:155:275-287. [Abstract]
Twist1, nuclear NF-κB-p65 and secreted TNF-α in macrophages after transfection with Twist1 siRNA (100 pmol/well) for 48 h and then treatment with LPS, TT-TFM (200 μM) and T5224 (50 μM) for another 24 h.
-
Chem Biol Interact
4-Hydroxybenzoic acid restrains Nlrp3 inflammasome priming and activation via disrupting PU.1 DNA binding activity and direct antioxidation. [Abstract]2024 Dec 1:404:111262. PMID: 39389441 -
Cancer Metab
Subclinical dose irradiation triggers human breast cancer migration via mitochondrial reactive oxygen species. [Abstract]2024 Jul 8;12(1):20. PMID: 38978126 -
Commun Biol
Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos. [Abstract]2023 Jan 16;6(1):52. PMID: 36646927 -
Life Sci
Enhancement of lens extraction-induced MCP-1 upregulation and microglia response in long-term diabetes via c-jun, stat1 and ERK. [Abstract]2020 Nov 15;261:118360. PMID: 32861799 -
Stem Cells Transl Med
Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation. [Abstract]2025 Apr 22;14(4):szaf009. PMID: 40261200 -
Int J Mol Sci
The Corticosterone-Glucocorticoid Receptor-AP1/CREB Axis Inhibits the Luteinizing Hormone Receptor Expression in Mouse Granulosa Cells. [Abstract]2022 Oct 18;23(20):12454. PMID: 36293309 -
FASEB J
Neutrophil extracellular traps facilitate sympathetic hyperactivity by polarizing microglia toward M1 phenotype after traumatic brain injury. [Abstract]2023 Sep;37(9):e23112. PMID: 37534961 -
J Inflamm Res
CCL20 Expression via AKT-ERK1/2-AP1 Pathway in Mycoplasma Pneumoniae Infection: Implications for EMT and Cell Migration. [Abstract]2025 Apr 28:18:5727-5739. PMID: 40322529 -
Sci Rep
Enhancement of melanoma aggressiveness via p38-MAPK, HIF-1α pathways, and metabolic reprogramming induced by Candida albicans. [Abstract]2025 Nov 17;15(1):40227. PMID: 41249785 -
-
Sci Rep
Anti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway. [Abstract]2020 Oct 22;10(1):18119. PMID: 33093618 -
Clin Transl Immunology
SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses. [Abstract]2024 Apr 15;13(4):e1503. PMID: 38623540 -
J Virol
Critical Role of Viral Protein Hexon in Hypervirulent Fowl Adenovirus Serotype-4-Induced Autophagy by Interaction with BAG3 and Promotion of Viral Replication in LMH Cells. [Abstract]2023 Jun 29;97(6):e0028423. PMID: 37255472 -
Am J Pathol
Lipopolysaccharide Triggers Luminal Acidification to Promote Defense Against Bacterial Infection in Vaginal Epithelium. [Abstract]2024 Aug 31:S0002-9440(24)00328-6. PMID: 39222908 -
Stem Cells Int
Activator Protein-1 Transcriptional Activity Drives Soluble Micrograft-Mediated Cell Migration and Promotes the Matrix Remodeling Machinery. [Abstract]2019 Dec 31;2019:6461580. PMID: 32082384 -
Endocrinology
Microbiota-Dependent Induction of Colonic Cyp27b1 Is Associated With Colonic Inflammation: Implications of Locally Produced 1,25-Dihydroxyvitamin D3 in Inflammatory Regulation in the Colon. [Abstract]2017 Nov 1;158(11):4064-4075. PMID: 28938443
T-5224 purchased from MedChemExpress. Usage Cited in: Endocrinology. 2017 Nov 1;158(11):4064-4075. [Abstract]
Cyp27b1 induction by LPS or TNF-α is mediated by NF-κB. HCT116 cells are treated with 100 ng/mL LPS or 100 ng/mL TNF-α overnight in the presence or absence of 20 ng/mL T-5224 as indicated. Cyp27b1 protein levels are measured by Western blotting.
-
Pathol Res Pract
SALL1 promotes proliferation and metastasis and activates phosphorylation of p65 and JUN in colorectal cancer cells. [Abstract]2023 Oct:250:154827. PMID: 37741137 -
Int Immunol
NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4-JMJD3 axis. [Abstract]2023 Oct 6;35(10):497-509. PMID: 37478314 -
Cell Immunol
WISP-3 enhances proinflammatory cytokine IL-1β production in rheumatoid arthritis through the FAK, JNK and AP-1 pathways. [Abstract]2026 Apr 6:425:105103. PMID: 41955703 -
Toxicol Lett
Hepatocytic AP-1 and STAT3 contribute to chemotaxis in alphanaphthylisothiocyanate-induced cholestatic liver injury. [Abstract]2023 Jan 15:373:184-193. PMID: 36460194 -
Mol Pain
Curcumin relieves CFA-induced inflammatory pain by inhibiting the AP-1/c-Jun-CCL2-CCR2 pathway in the spinal dorsal horn. [Abstract]2025 Jan-Dec:21:17448069251323668. PMID: 39950445 -
BMC Pulm Med
c-Fos is a mechanosensor that regulates inflammatory responses and lung barrier dysfunction during ventilator-induced acute lung injury. [Abstract]2022 Jan 6;22(1):9. PMID: 34986829 -
Biomed Res Int
Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway. [Abstract]2023 Jan 12:2023:4050730. PMID: 36685669 -
J Orthop Res
2017 Feb;35(2):311-320. PMID: 27082319 -
Biochem Biophys Rep
Up-regulation of NGEF via the BRAFV600E /ERK/AP1 pathway enhances invasion and migration abilities of BRAFV600E-mutant thyroid cancer. [Abstract]2025 Jul 17:43:102164. PMID: 40703409 -
In Vitro Cell Dev Biol Anim
Lactiplantibacillus plantarum promotes lactoferrin synthesis and secretion in bovine mammary epithelial cells through STAT3 and AP-1 transcription factor pathways. [Abstract]2025 Aug;61(7):886-897. PMID: 40802133 -
-
-
Npj Viruses
2025 Sep 18;3(1):69. PMID: 40968155 -
bioRxiv
2025 Aug 21:2025.08.15.670603. PMID: 40894800 -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Int J Biol Sci
Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF/CXCLs positive feedback loop. [Abstract]2022 Jan 16;18(4):1363-1380. PMID: 35280694 -
-
ACS Comb Sci
Benzimidazolyl-pyrazolo[3,4- b]pyridinones, Selective Inhibitors of MOLT-4 Leukemia Cell Growth and Sea Urchin Embryo Spiculogenesis: Target Quest. [Abstract]2019 Dec 9;21(12):805-816. PMID: 31689077
Solvent & Solubility
DMSO : 100 mg/mL (193.23 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: 5 mg/mL (9.66 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (50.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Add each solvent one by one: 50% PEG400 50% Saline
Solubility: 5 mg/mL (9.66 mM); Suspended solution; Need ultrasonic
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
HSC-3-M3 cells are starved for 24 h with DMEM containing 0.5% FBS. The top chamber of the cell invasion device is coated with 50 μL of 0.1 × basement membrane extract solution and incubataed overnight. HSC-3-M3 cells (5.0 × 104 cells/well) are added to the top chamber with DMEM containing 0.5% FBS mixed with 0-80 μM T-5224; DMEM with 10% FBS is added to the bottom chamber and incubated for 48 h. The bottom plate is read using a multilabel plate reader. The data are compared with the standard curve to determine the fraction of invaded cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Mice in LPS group are administered orally with polyvinylpyrrolidone solution in the same volume of T-5224 solution immediately after LPS injection, while in the T-5224 group, mice are administered orally with T-5224 (300 mg/kg, p.o.) in the same manner. In the control group, mice receives polyvinylpyrrolidone solution orally soon after intraperitoneal saline injection. Blood samples are collected for each measurement at the optimal time.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (396 KB)
- English - EN (396 KB)
- Français - FR (396 KB)
- Deutsch - DE (396 KB)
- Norwegian - NO (396 KB)
- Español - ES (396 KB)
- Swedish - SV (396 KB)
- Italian - IT (396 KB)
- Portuguese - PT (396 KB)
-
Handling Instructions (2659 KB)
References
[1]. Makino H, et al. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebraldisc degeneration and associated pain. Sci Rep. 2017 Dec 5;7(1):16983. [Content Brief]
[2]. Aikawa Y, et al. Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nat Biotechnol. 2008 Jul;26(7):817-23. [Content Brief]
[3]. Kamide D, et al. Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model. Cancer Sci.?2016 May;107(5):666-73. [Content Brief]
[4]. Izuta S, et al. T-5224, a selective inhibitor of c-Fos/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice. Biotechnol Lett. 2012 Dec;34(12):2175-82. [Content Brief]
[5]. Uchihashi S, et al. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Drug Metab Dispos. 2011 May;39(5):803-13. [Content Brief]
[6]. Miyazaki H, et al. The effects of a selective inhibitor of c-Fos/activator protein-1 on endotoxin-induced acute kidney injury in mice. BMC Nephrol. 2012 Nov 23;13:153. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9323 mL | 9.6613 mL | 19.3226 mL | 48.3064 mL |
| 5 mM | 0.3865 mL | 1.9323 mL | 3.8645 mL | 9.6613 mL | |
| 10 mM | 0.1932 mL | 0.9661 mL | 1.9323 mL | 4.8306 mL | |
| 15 mM | 0.1288 mL | 0.6441 mL | 1.2882 mL | 3.2204 mL | |
| 20 mM | 0.0966 mL | 0.4831 mL | 0.9661 mL | 2.4153 mL | |
| 25 mM | 0.0773 mL | 0.3865 mL | 0.7729 mL | 1.9323 mL | |
| 30 mM | 0.0644 mL | 0.3220 mL | 0.6441 mL | 1.6102 mL | |
| 40 mM | 0.0483 mL | 0.2415 mL | 0.4831 mL | 1.2077 mL | |
| 50 mM | 0.0386 mL | 0.1932 mL | 0.3865 mL | 0.9661 mL | |
| 60 mM | 0.0322 mL | 0.1610 mL | 0.3220 mL | 0.8051 mL | |
| 80 mM | 0.0242 mL | 0.1208 mL | 0.2415 mL | 0.6038 mL | |
| 100 mM | 0.0193 mL | 0.0966 mL | 0.1932 mL | 0.4831 mL |